ASM International Exceeds Expectations with Strong Bookings and Raised Guidance

ASM International reported €800 million in Q4 bookings today. The company beat analyst forecasts and raised its growth outlook for the first quarter of 2026.

Insights:
ASM International NV , Europe's second-largest semiconductor equipment manufacturer, released an unscheduled statement on January 19, 2026, revealing preliminary fourth-quarter results that substantially beat market expectations. The firm reported preliminary bookings of approximately €800 million for the final quarter of 2025, exceeding the analyst consensus forecast of €669 million from a Visible Alpha poll by about 20%. This surge was driven by a significant rebound in orders from China CNCNand robust performance in the advanced logic/foundry segment.
In addition to the strong booking figures, ASM International NVreported preliminary fourth-quarter revenue of €698 million, ahead of the €656 million estimate from an LSEG poll. Consequently, the company has upgraded its outlook for the first quarter of 2026. Moving away from a previously cautious forecast of a slow start to the year, the company now expects a healthy revenue increase on a constant currency basis. This update provides a positive signal for the broader industry, affecting major players like ASML Holding NV , Applied Materials Inc , Lam Research Corporation , and KLA Corporation .
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.